| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |